VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. ABBV

Go back to VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
VolitionRX Limited (NYSE: VNRX) Delayed: 1.36 -0.07 (4.9%)
Previous Close $1.43    52 Week High $5.86 
Open $1.43    52 Week Low $3.05 
Day High $1.45    P/E N/A 
Day Low $1.32    EPS $-0.45 
Volume 280,810       

VolitionRX Limited (NYSE: VNRX) Delayed: 1.36 -0.07 (4.9%)
Previous Close $1.43    52 Week High $5.86 
Open $1.43    52 Week Low $3.05 
Day High $1.45    P/E N/A 
Day Low $1.32    EPS $-0.45 
Volume 280,810